The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the ...

Diabetes specialist Novo Nordisk is feeling the heat from increasingly ... This great success was founded on successive innovation in insulin products and user-friendly insulin pen devices.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Apollo Global Management, Novo Nordisk A/S, BlackRock, Blackstone, and Prologis are the five Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...

Vivani Medical, Inc. ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the successful administration of its ...

Vivani Medical will spin off Cortigent, its neurostimulation business, as an independently publicly traded company as it ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.